Ivan F. McMurtry
About
Ivan F. McMurtry is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology.
According to data from OpenAlex, Ivan F. McMurtry has authored 204 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Pulmonary and Respiratory Medicine, 100 papers in Physiology and 46 papers in Molecular Biology. Recurrent topics in Ivan F. McMurtry's work include Pulmonary Hypertension Research and Treatments (96 papers), Nitric Oxide and Endothelin Effects (93 papers) and Neuroscience of respiration and sleep (43 papers). Ivan F. McMurtry is often cited by papers focused on Pulmonary Hypertension Research and Treatments (96 papers), Nitric Oxide and Endothelin Effects (93 papers) and Neuroscience of respiration and sleep (43 papers). Ivan F. McMurtry collaborates with scholars based in United States, Japan and United Kingdom. Ivan F. McMurtry's co-authors include Masahiko Oka, David M. Rodman, Karen A. Fagan, Steven H. Abman, Richard F. OʼBrien, Kenneth G. Morris, Kurt R. Stenmark, Sarah A. Gebb, Karyl M. VanBenthuysen and Lawrence D. Horwitz and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.
In The Last Decade
Ivan F. McMurtry
204 papers receiving 12.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ivan F. McMurtry United States | 61 | 7.1k | 4.9k | 3.3k | 3.2k | 1.8k | 204 | 12.3k | ||
| Adel Giaid Canada | 47 | 3.8k 0.5× | 4.1k 0.8× | 3.4k 1.0× | 2.3k 0.7× | 835 0.5× | 115 | 11.2k | ||
| Serge Adnot France | 65 | 8.0k 1.1× | 2.8k 0.6× | 3.7k 1.1× | 2.9k 0.9× | 729 0.4× | 215 | 12.4k | ||
| Ralph T. Schermuly Germany | 72 | 13.8k 2.0× | 3.2k 0.6× | 6.2k 1.9× | 5.8k 1.8× | 962 0.5× | 397 | 20.0k | ||
| Jason X.‐J. Yuan United States | 60 | 5.9k 0.8× | 2.1k 0.4× | 2.9k 0.9× | 5.5k 1.7× | 608 0.3× | 199 | 11.8k | ||
| Saadia Eddahibi France | 54 | 6.8k 1.0× | 1.8k 0.4× | 3.3k 1.0× | 1.9k 0.6× | 527 0.3× | 128 | 8.9k | ||
| Stella Kourembanas United States | 49 | 3.9k 0.6× | 1.8k 0.4× | 991 0.3× | 6.0k 1.9× | 1.1k 0.6× | 111 | 11.4k | ||
| Larissa A. Shimoda United States | 51 | 3.2k 0.5× | 2.4k 0.5× | 1.2k 0.4× | 4.0k 1.3× | 1.3k 0.7× | 131 | 9.5k | ||
| Philip A. Marsden Canada | 62 | 1.3k 0.2× | 5.1k 1.0× | 2.6k 0.8× | 4.8k 1.5× | 606 0.3× | 151 | 12.7k | ||
| Gabor M. Rubanyi United States | 48 | 1.2k 0.2× | 6.6k 1.3× | 4.4k 1.4× | 3.5k 1.1× | 590 0.3× | 173 | 13.2k | ||
| Mark A. Perrella United States | 62 | 1.5k 0.2× | 1.9k 0.4× | 1.9k 0.6× | 7.0k 2.2× | 682 0.4× | 169 | 12.9k |
Countries citing papers authored by Ivan F. McMurtry
Since
Specialization
Citations
This map shows the geographic impact of Ivan F. McMurtry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan F. McMurtry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan F. McMurtry more than expected).
Fields of papers citing papers by Ivan F. McMurtry
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ivan F. McMurtry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan F. McMurtry. The network helps show where Ivan F. McMurtry may publish in the future.
Co-authorship network of co-authors of Ivan F. McMurtry
This figure shows the co-authorship network connecting the top 25 collaborators of Ivan F. McMurtry. A scholar is included among the top collaborators of Ivan F. McMurtry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan F. McMurtry. Ivan F. McMurtry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Al‐Hilal, Taslim A., Ali Keshavarz, Hossam Kadry, et al.. (2020). Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application. Lab on a Chip. 20(18). 3334–3345.
2.
Keshavarz, Ali, Ahmed Alobaida, Ivan F. McMurtry, et al.. (2019). CAR, a Homing Peptide, Prolongs Pulmonary Preferential Vasodilation by Increasing Pulmonary Retention and Reducing Systemic Absorption of Liposomal Fasudil. Molecular Pharmaceutics. 16(8). 3414–3429.
3.
Oshima, K., Sachindra Raj Joshi, Jared M. McLendon, et al.. (2019). Aneurysm-type plexiform lesions form in supernumerary arteries in pulmonary arterial hypertension: potential therapeutic implications. American Journal of Physiology-Lung Cellular and Molecular Physiology. 317(6). L805–L815.
4.
Gairhe, Salina, Sachindra Raj Joshi, Jared M. McLendon, et al.. (2016). Sphingosine‐1‐Phosphate is Involved in the Occlusive Arteriopathy of Pulmonary Arterial Hypertension. Pulmonary Circulation. 6(3). 369–380.
5.
McLendon, Jared M., Sachindra Raj Joshi, Majed Matar, et al.. (2015). Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension. Journal of Controlled Release. 210. 67–75.
6.
Alzoubi, Abdallah, Michie Toba, Kohtaro Abe, et al.. (2013). Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension. American Journal of Physiology-Heart and Circulatory Physiology. 304(12). H1708–H1718.
7.
Gairhe, Salina, Natalie Bauer, Sarah A. Gebb, & Ivan F. McMurtry. (2012). Serotonin passes through myoendothelial gap junctions to promote pulmonary arterial smooth muscle cell differentiation. American Journal of Physiology-Lung Cellular and Molecular Physiology. 303(9). L767–L777.
8.
Abe, Kohtaro, Michie Toba, Abdallah Alzoubi, et al.. (2011). Tyrosine Kinase Inhibitors Are Potent Acute Pulmonary Vasodilators in Rats. American Journal of Respiratory Cell and Molecular Biology. 45(4). 804–808.
9.
Abe, Kohtaro, Michie Toba, Abdallah Alzoubi, et al.. (2010). Formation of Plexiform Lesions in Experimental Severe Pulmonary Arterial Hypertension. Circulation. 121(25). 2747–2754.
10.
Homma, Noriyuki, Tetsutaro Nagaoka, Vijaya Karoor, et al.. (2008). Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone. American Journal of Physiology-Lung Cellular and Molecular Physiology. 295(1). L71–L78.
11.
Laudi, Sven, Saskia Trump, Volker Schmitz, et al.. (2007). Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin. American Journal of Physiology-Lung Cellular and Molecular Physiology. 293(3). L630–L638.
12.
Nagaoka, Tetsutaro, Karen A. Fagan, Sarah A. Gebb, et al.. (2004). Inhaled Rho Kinase Inhibitors Are Potent and Selective Vasodilators in Rat Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 171(5). 494–499.
13.
Fagan, Karen A., Masahiko Oka, Natalie R. Bauer, et al.. (2004). Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. American Journal of Physiology-Lung Cellular and Molecular Physiology. 287(4). L656–L664.
14.
Fagan, Karen A., Brian Fouty, Robert Claude Tyler, et al.. (1999). The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. Journal of Clinical Investigation. 103(2). 291–299.
15.
Tyler, Robert Claude, Clayton Bullock, Cori Gorman, et al.. (1997). Polycationic Lipid-Mediated Gene Transfer to the Abnormal Pulmonary Circulation. CHEST Journal. 111(6). 122S–123S.
16.
Chetham, Paul M., et al.. (1997). Inhaled Nitric Oxide Pretreatment But Not Post-treatment Attenuates Ischemia-Reperfusion-induced Pulmonary Microvascular Leak . Anesthesiology. 86(4). 895–902.
17.
Oka, Masahiko, K G Morris, & Ivan F. McMurtry. (1993). NIP-121 is more effective than nifedipine in acutely reversing chronic pulmonary hypertension. Journal of Applied Physiology. 75(3). 1075–1080.
18.
Oka, Masahiko, K. Hasunuma, S. Webb, et al.. (1993). EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs. American Journal of Physiology-Lung Cellular and Molecular Physiology. 264(6). L587–L597.
19.
Rodman, David M., et al.. (1991). Difference in Effect of Inhibitors of Energy Metabolism on Endothelium-dependent Relaxation of Rat Pulmonary Artery and Aorta. American Journal of Respiratory Cell and Molecular Biology. 4(3). 237–242.
20.
Newman, John H., Ivan F. McMurtry, & John Τ. Reeves. (1981). Blunted pulmonary pressor responses to hypoxia in blood perfused, ventilated lungs isolated from oxygen toxic rats: Possible role of prostaglandins. Prostaglandins. 22(1). 11–20.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Adel Giaid Breakdown of academic impact, for papers by Serge Adnot Breakdown of academic impact, for papers by Ralph T. Schermuly Breakdown of academic impact, for papers by Jason X.‐J. Yuan Breakdown of academic impact, for papers by Saadia Eddahibi Breakdown of academic impact, for papers by Stella Kourembanas Breakdown of academic impact, for papers by Larissa A. Shimoda Breakdown of academic impact, for papers by Philip A. Marsden Breakdown of academic impact, for papers by Gabor M. Rubanyi Breakdown of academic impact, for papers by Mark A. Perrella